ONCOVIN Drug Patent Profile
✉ Email this page to a colleague
When do Oncovin patents expire, and when can generic versions of Oncovin launch?
Oncovin is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in ONCOVIN is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ONCOVIN?
- What are the global sales for ONCOVIN?
- What is Average Wholesale Price for ONCOVIN?
Summary for ONCOVIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 204 |
Patent Applications: | 4,206 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ONCOVIN at DailyMed |
![ONCOVIN drug patent expirations Drug patent expirations by year for ONCOVIN](/p/graph/s/t/ONCOVIN-patent-expirations.png)
Recent Clinical Trials for ONCOVIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical College of Wisconsin | Phase 1 |
Innovent Biologics (Suzhou) Co. Ltd. | Phase 2 |
Yazeed Sawalha | Phase 1 |
US Patents and Regulatory Information for ONCOVIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | ONCOVIN | vincristine sulfate | INJECTABLE;INJECTION | 014103-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | ONCOVIN | vincristine sulfate | INJECTABLE;INJECTION | 014103-003 | Mar 7, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | ONCOVIN | vincristine sulfate | INJECTABLE;INJECTION | 014103-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ONCOVIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lilly | ONCOVIN | vincristine sulfate | INJECTABLE;INJECTION | 014103-003 | Mar 7, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ONCOVIN
See the table below for patents covering ONCOVIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 553514 | ⤷ Sign Up | |
United Kingdom | 8319146 | ⤷ Sign Up | |
Italy | 1170152 | MIGLIORAMENTI A O RIGUARDANTI FORMULAZIONI DI VINCA-ALCALOIDI | ⤷ Sign Up |
France | 2531860 | PERFECTIONNEMENTS A DES COMPOSITIONS D'ALCALOIDES DE VINCA | ⤷ Sign Up |
Germany | 3324964 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |